Abstract Background Although Endoscopic Submucosal Dissection (ESD) was proven
superior to Endoscopic Mucosal Resection (EMR) in achieving higher complete remission …

BACKGROUND: EMR is commonly performed before radiofrequency ablation (RFA) for
nodular dysplastic Barrett's esophagus (BE). OBJECTIVE: To determine the efficacy and …

Background High-grade dysplasia (HGD) and intramucosal carcinoma (IMC) in Barrett's
esophagus (BE) are now well-established indications for endoscopic resection (ER) …

Background: After endoscopic resection (ER) of high-grade dysplasia (HGD) and early
cancer (EC) in Barrett esophagus (BE), the residual BE remains at risk for neoplasia …

Background: Endoscopic resection (ER) allows for removal of high-grade dysplasia (HGD)
and intramucosal cancer (IMC) in Barrett's esophagus (BE), providing a large specimen for …

The effects of preceding endoscopic mucosal resection (EMR) on the efficacy and safety of
radiofrequency ablation (RFA) for treatment of nodular Barrett's esophagus (BE) is poorly …

Background In patients with Barrett's esophagus (BE) containing high-grade dysplasia
(HGD) or early cancer (EC), radiofrequency ablation (RFA) with prior endoscopic resection …

Background and study aim Both endoscopic mucosal resection (EMR) and radiofrequency
ablation (RFA) are used to treat Barrett's esophagus (BE) complicated by dysplasia and …

Objective: Radiofrequency ablation (RFA) is a novel endoscopic ablation technique for
eradication of Barrett esophagus (BE) with and without dysplasia. Aim: To report the …

The current standard of treating early Barrett's neoplasia is resection of visible lesions using
endoscopic mucosal resection (EMR) followed by ablative therapy to the Barrett's segment …